Most articles on choosing a CRO partner tell you the same thing. Look for experience. Check regulatory expertise. Ask about quality systems. This advice is not necessarily wrong, but it is not very useful either. Almost every CRO company will claim to tick these boxes on their website.
The real problem is different. Sponsors usually know what to look for. What they don’t have is a simple way to test for it before they sign a contract. This post is meant to fix that gap. It gives you a practical checklist you can actually use while evaluating a CRO in India, along with the red flags that most sponsors only notice after it’s too late.
Before you Talk to any CRO, get your Own Scope Right
A lot of CRO selection problems start on the sponsor’s side, not the CRO’s side. If your own requirements are vague, even a strong CRO partner will struggle to give you an accurate proposal.
Before you start reaching out, write down:
- The trial phase (Phase I to IV) and therapeutic area
- Whether you need a full-service CRO or support in specific functions only
- The countries and sites involved
- Your timeline and any hard deadlines (like a funding milestone)
- Rough budget assumptions
If you are not sure whether you need a full-service partner or a functional model, it’s worth reading our earlier post on Full-Service CRO vs FSP Model in India before you go further. Getting this decision right changes how you should evaluate proposals later.
Once this is clear, you are in a much better position to compare CRO companies against each other, since everyone is responding to the same brief.
The Evaluation Checklist, Step-by-Step
Rather than treating this as one long list of things to “check,” it helps to break the evaluation into stages. Each stage has its own questions.
Stage 1: When you Review the Proposal
Do not just read what the CRO says about itself. Ask direct questions and see how specific the answers are.
| What to ask | Why it matters |
| Show me 2-3 studies in my therapeutic area and phase | Generic experience is not the same as relevant experience |
| How do you handle CDSCO or FDA queries in a trial like mine? | Ask how the CRO handles CDSCO or FDA queries and whether it has dedicated regulatory support for clinical trials throughout the study lifecycle rather than only at the submission stage. |
| What does your quality management system actually cover? | A real QMS should work alongside effective clinical trial monitoring, with clear processes for identifying deviations, managing site performance and escalating compliance risks. |
| What systems do you use for EDC, CTMS, and data management? | Ask what systems the CRO uses for EDC, CTMS and clinical data management, and how those systems support data quality, query management, reporting and study oversight. |
| How do you plan to recruit patients for this specific protocol? | Look for site-level detail, not a general claim about India’s patient pool |
A vague answer to any of these is worth noting. It usually shows up again later in the trial.
Stage 2: The Bid Defence or Team Meeting
This is the most important stage, and the one sponsors skip too quickly.
- Ask who will actually be on your study team, by name and role, not just by job title
- Confirm that the people in the meeting are the people who will run your trial, not just the sales team
- Present a simple “what if” scenario, like a site underperforming on recruitment, and ask how they would respond
- Ask who has the authority to make decisions without escalating every issue, and how the CRO’s clinical trial project management structure handles delays, cross-functional decisions and study milestones.
If the answers feel rehearsed or the team cannot go beyond the slide deck, that’s useful information.
Stage 3: Reference Checks
Do not settle for “were you happy with them.” Ask sharper questions instead:
- Did the team you met during the pitch stay on the project?
- Were recruitment timelines met, and if not, how was it handled?
- How did they communicate delays or problems?
- Would you use them again for a similar trial?
Stage 4: Contract and Governance
Before signing, make sure these are written down clearly, not just discussed verbally:
- Who owns the trial data during and after the contract
- How change orders are priced and approved
- What the escalation path looks like if something goes wrong
- What happens if a site or vendor underperforms
Warning Signs to Watch for
Some red flags are easy to miss because they look like normal sales behaviour. Watch for these specifically:
- Recruitment timelines that sound optimistic but are not backed by site-level data
- A study team that changes soon after the contract is signed
- Vague answers about therapeutic area experience, dressed up in general language
- Pricing with no clear breakdown between professional fees, technology costs, and site payments
- No clear owner for decisions when something goes wrong mid-trial
We have written in more detail about this in The Hidden Risks of Choosing the Wrong CRO in India, which covers how small early warning signs tend to turn into bigger problems later in a trial.
A Simple Way to Score your Options
Once you have proposals from 2-3 CRO companies, a basic scorecard makes comparison easier than going on gut feeling. Score each area from 1 to 5 and weight it by what matters most for your trial.
| Evaluation area | Weight | CRO A | CRO B | CRO C |
| Therapeutic and phase experience | High | |||
| Regulatory capability | High | |||
| Quality and monitoring systems | High | |||
| Recruitment strategy and site network | Medium | |||
| Technology and data systems | Medium | |||
| Governance and communication | Medium | |||
| Cost transparency | Medium |
This will not replace judgment, but it forces the comparison to be based on evidence rather than impressions.
What’s Different About Doing this in India
India offers real advantages for clinical trials: a large and diverse patient population, skilled investigators, and a regulatory framework that has matured significantly over the past few years. But these advantages depend heavily on which CRO partner you choose, and even more on which sites and investigators they actually work with.
A few things worth knowing if you are new to running trials here:
- CDSCO timelines can vary by therapeutic area and trial type, so ask your CRO for realistic estimates rather than best-case ones
- Site quality varies significantly across cities, so a broad network on paper is not the same as strong sites for your specific protocol
- Many established CRO companies operate out of the Delhi NCR region, including a CRO in Delhi or nearby Noida, which can be useful if you want a partner within easy reach of regulatory bodies and major research hospitals
None of this replaces the checklist above. It just means the stakes for asking good questions are a little higher when you are choosing a CRO in India for the first time.
Best CRO Partner in India: Why Sponsors Choose Innovate Research
If you’re comparing CRO companies in India, Innovate Research is a partner worth knowing well.
Services
Innovate offers end-to-end support across the trial lifecycle, so sponsors don’t need to juggle multiple vendors:
- Clinical trial monitoring (on-site, remote, and risk-based)
- Regulatory affairs, including CDSCO and FDA submissions
- Medical writing and clinical study reports
- Biostatistics and data integrity support
- Project management from study start to close-out
For studies where statistical design is important, sponsors should also evaluate the CRO’s clinical biostatistics capabilities, including study design, sample-size calculations, statistical analysis planning and interpretation.
Why sponsors choose Innovate
A few reasons sponsors keep coming back to us:
- One CRO partner for regulatory, monitoring, biostatistics, and medical writing, instead of separate vendors for each
- Hands-on project management, especially useful for sponsors running their first India trial
- Direct access to senior team members, including the founder
- Experience across both conventional pharma and nutraceutical trials
Innovate runs on its own technology, ClinSoft and PageOne, for data capture and trial management. Founder Dr. Devesh Kumar stays closely involved, particularly in nutraceutical and clinical validation work. With a presence in India, the US, Dubai, Hungary, and the UK, we support sponsors well beyond a single-country footprint.
Final Thought
Choosing a CRO partner is not really about finding a company that says the right things. It’s about finding one that can show you, with specifics, how they will handle your trial. A good contract research organization will not mind being questioned this closely. If anything, sponsors who run a thorough evaluation tend to get better proposals and better working relationships once the trial starts.
If you are currently evaluating CRO selection criteria for an upcoming study, we are happy to walk through our approach and answer these same questions directly. Visit Innovate Research to learn more about our services.
FAQs
- Does a CRO in India need to be registered with CDSCO?
Yes. From 1 April 2025, CRO registration with India’s Central Licensing Authority became mandatory for organisations conducting clinical trials or bioavailability/bioequivalence studies involving new drugs or investigational new drugs in human participants. Registration is granted in Form CT-07C and is generally valid for five years unless suspended or cancelled.
- If a pharma sponsor hires a CRO, does the CRO become fully responsible for the clinical trial?
No. A sponsor can transfer many trial-related activities to a CRO, but the sponsor retains ultimate responsibility for participant safety and the reliability of trial data. ICH E6(R3) also states that transferred responsibilities should be documented clearly, while responsibilities that are not specifically transferred remain with the sponsor.
- Can a foreign pharmaceutical company conduct a clinical trial in India without having its own local office?
A foreign sponsor generally needs appropriate local representation to handle regulatory and operational responsibilities in India. Current India clinical-trial guidance notes that a foreign sponsor may appoint a local representative or CRO to fulfil these responsibilities. The exact arrangement should be defined clearly before regulatory submissions begin.
- Does a clinical trial in India need to be registered with CTRI before patients are enrolled?
Yes. Clinical trials conducted in India are required to be registered with the Clinical Trials Registry–India (CTRI). Current requirements call for registration before the first study participant is enrolled. Sponsors evaluating a CRO should therefore ask whether CTRI registration and ongoing record updates are included within the CRO’s regulatory scope.
- Can a CRO subcontract parts of a clinical trial to other vendors?
Yes, CROs may work with additional service providers for activities such as laboratories, technology, logistics or specialist trial functions. However, ICH E6(R3) states that sponsors should maintain appropriate oversight of important trial activities, including activities that are further subcontracted by a service provider. Sponsors should therefore ask a CRO which functions will remain in-house and which will be outsourced before signing the contract.
- What should sponsors ask a CRO about serious adverse event reporting in India?
Sponsors should confirm who receives, reviews, escalates and submits safety information when a serious adverse event occurs. Under India’s New Drugs and Clinical Trials Rules, investigators must report SAEs to the Central Licensing Authority, sponsor or its representative, and Ethics Committee within 24 hours. Additional analysed reports are also subject to defined timelines. A CRO should therefore have a clear pharmacovigilance workflow rather than relying on informal communication between the site and sponsor.